tiprankstipranks
Biogen (BIIB)
NASDAQ:BIIB

Biogen (BIIB) Technical Analysis

4,422 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Biogen’s (BIIB) Moving Averages Convergence Divergence (MACD) indicator is 0.23, suggesting Biogen is a Buy.
Biogen’s (BIIB) 20-Day exponential moving average is 227.46, while Biogen’s (BIIB) share price is $226.4, making it a Sell.
Biogen’s (BIIB) 50-Day exponential moving average is 225.53, while Biogen’s (BIIB) share price is $226.4, making it a Buy.

Biogen (BIIB) Pivot Points

Jul 22, 2024, 04:44 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
213.97
218.64
221.94
226.61
229.91
234.58
237.88
Fibonacci
218.64
221.68
223.56
226.61
229.65
231.53
234.58
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biogen (BIIB) Moving Averages

Jul 22, 2024, 04:44 AM
Period
Simple
Exponential
MA5
225.32Buy
226.62Sell
MA10
228.33Sell
227.29Sell
MA20
227.65Sell
227.46Sell
MA50
226.90Sell
225.53Buy
MA100
219.46Buy
225.94Buy
MA200
231.96Sell
235.63Sell
Biogen’s (BIIB) 10-Day exponential moving average is 227.29, while Biogen’s (BIIB) share price is $226.4, making it a Sell.
Biogen’s (BIIB) 100-Day exponential moving average is 225.94, while Biogen’s (BIIB) share price is $226.4, making it a Buy.
Biogen’s (BIIB) stock price is $226.4 and Biogen’s (BIIB) 50-day simple moving average is 226.90, creating a Sell signal.
Biogen’s (BIIB) stock price is $226.4 and Biogen’s (BIIB) 100-day simple moving average is 219.46, creating a Buy signal.
Biogen’s (BIIB) stock price is $226.4 and Biogen’s (BIIB) 200-day simple moving average is 231.96, creating a Sell signal.

Biogen (BIIB) Technical Indicators

Jul 22, 2024, 04:44 AM
Name
Value
Implied Action
RSI (14)
49.15
Neutral
STOCH (9,6)
34.03
Neutral
STOCHRSI (14)
34.03
Neutral
MACD (12,26)
0.23
Buy
ADX (14)
11.05
Buy
Williams %R
-67.48
Buy
CCI (14)
-53.91
Neutral
ATR (14)
6.51
-
Ultimate Oscillator
47.18
Neutral
ROC
-2.34
Sell
Biogen’s (BIIB) Relative Strength Index (RSI) is 49.15, creating a Neutral signal.
Biogen’s (BIIB) Trend Strength Indicator (ADX) is 11.05, creating a Buy signal.
Biogen’s (BIIB) Commodity Channel Index (CCI) is -53.91, creating a Neutral signal.
Biogen’s (BIIB) Price Rate of Change (ROC) is -2.34, creating a Sell signal.

FAQ

Is BIIB a Buy, Hold, or Sell?
Based on BIIB’s technical indicators, BIIB is a Sell.
    What is BIIB’s RSI (14)?
    BIIB’s RSI (14) is 49.15, which suggests BIIB is a Neutral.
      What is BIIB’s MACD?
      BIIB’s MACD is 0.23, which suggests BIIB is a Buy.
        What is BIIB’s 5-day moving average?
        BIIB’s 5-day moving average is 225.32, which suggests BIIB is a Buy.
          What is BIIB’s 20-day moving average?
          BIIB 20-day moving average is 227.65, which suggests BIIB is a Sell.
            What is BIIB’s 50-day moving average?
            BIIB’s 50-day moving average is 226.90, which suggests BIIB is a Sell.
              What is BIIB’s 200-day moving average?
              BIIB’s 200-day moving average is 231.96, which suggests BIIB is a Sell.
                What is BIIB’s Williams % R (14)?
                BIIB’s Williams % R (14) is -67.48, which suggests BIIB is a Buy.
                  What is BIIB’s CCI (14)?
                  BIIB’s CCI (14) is -53.91, which suggests BIIB is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis